Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer

Por Bothwell, Katelyn D., Folaron, Margaret, Seshadri, Mukund
Publicado no Cancers (Basel) (2016)

Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer

Por Kalmuk, James, Folaron, Margaret, Buchinger, Julian, Pili, Roberto, Seshadri, Mukund
Publicado no Oncotarget (2015)

Vascular Priming Enhances Chemotherapeutic Efficacy against Head and Neck Cancer

Por Folaron, Margaret, Kalmuk, James, Lockwood, Jaimee, Frangou, Costakis, Vokes, Jordan, Turowski, Steven G., Merzianu, Mihai, Rigual, Nestor R., Sullivan-Nasca, Maureen, Kuriakose, Moni A., Hicks, Wesley L., Singh, Anurag K., Seshadri, Mukund
Publicado em 2013